hMG

Human menopausal gonadotropin preparations contain follicle-stimulating and luteinizing hormone activity and are studied and used in reproductive endocrinology.

FSH and LH receptor activation supports follicular development, steroidogenesis, and gametogenic signaling.

Established human evidence and approved prescription products.

Level I, Established human evidence

Activity depends on source, purification, FSH-to-LH activity, bioassay, and formulation. Research material cannot be presumed equivalent to an approved menotropin product.

Approved-use risks include ovarian hyperstimulation, thromboembolism, multiple gestation, and endocrine adverse effects.

Prescription gonadotropin category; direct consumer RUO positioning requires separate regulatory review.

Supplied strictly for in-vitro and ex-vivo laboratory research. Not for human or veterinary administration, diagnostic, or therapeutic use. Import and regulatory compliance remain the responsibility of the receiving researcher.

• hMG, 75 IULyophilized

Every Cendrix lot ships with an HPLC purity chromatogram, mass-spectrometry identity confirmation, appearance and reconstitution observations, and endotoxin testing where applicable. Lot certificates are retrievable from the Quality page using the lot number printed on the vial.

External searches link to PubMed, ClinicalTrials.gov, Google Scholar, and FDA records. Cendrix does not endorse interpretations published in third-party sources.